comparemela.com

Nasdaq Aadi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HC Wainwright Reiterates Neutral Rating for Aadi Bioscience (NASDAQ:AADI)

HC Wainwright reaffirmed their neutral rating on shares of Aadi Bioscience (NASDAQ:AADI – Free Report) in a research report released on Tuesday morning, Benzinga reports. HC Wainwright also issued estimates for Aadi Bioscience’s Q2 2024 earnings at ($0.66) EPS, Q4 2024 earnings at ($0.71) EPS, FY2024 earnings at ($2.73) EPS, Q1 2025 earnings at ($0.73) […]

Aadi Bioscience (AADI) Set to Announce Quarterly Earnings on Wednesday

Aadi Bioscience (NASDAQ:AADI – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, May 8th. Analysts expect Aadi Bioscience to post earnings of ($0.66) per share for the quarter. Aadi Bioscience (NASDAQ:AADI – Get Free Report) last posted its quarterly earnings results on Wednesday, March 13th. […]

Aadi Bioscience (AADI) Scheduled to Post Quarterly Earnings on Wednesday

Aadi Bioscience (NASDAQ:AADI – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.66) per share for the quarter. Aadi Bioscience (NASDAQ:AADI – Get Free Report) last posted its quarterly earnings data on Wednesday, March 13th. The […]

Reviewing Aadi Bioscience (NASDAQ:AADI) and Statera Biopharma (NASDAQ:STAB)

Aadi Bioscience (NASDAQ:AADI – Get Free Report) and Statera Biopharma (NASDAQ:STAB – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Profitability This table compares Aadi Bioscience and […]

Aadi Bioscience, Inc (NASDAQ:AADI) Chairman Sells $73,080 00 in Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 42,000 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $1.74, for a total value of $73,080.00. Following the completion of the sale, the chairman now owns 1,453,543 shares […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.